Taken together, these studies highlight the differential behaviors of PKM2 activators and the requirement for more in-depth investigations into the proposed mechanisms of action and subsequent physiological, biochemical, and clinical outcomes of using these compounds as a potential therapeutic approach for the treatment of cancer. The gene discussed is PKM; the disease is cancer.